how many people in the us take glp 1 According to poll, the share of U.S. adults currently taking GLP-1 medications for weight loss has climbed to 11% 2026, up from 3% just two years ago. 🔗⬇️ With about 11% of Americans

Abstract Introduction Glucagon-like peptide-1 receptor agonist use has increased over the last decade for glycemic control in type 2 diabetes mellitus, cardiovascular risk reduction, and weight loss

You have a current or past diagnosis of anorexia or bulimia

What to Expect from a Supervised Program If you are considering a medication like Wegovy or a compounded alternative, a professional program should include: Initial Clinical Review: A thorough check of your BMI, health history, and goals

Give yourself the time, grace, and patience to start from where youre at and work your way into a consistent routine thats maintainable for the long term this is where youll find the best results